![Marie-Paul Lachaud](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marie-Paul Lachaud
Geen lopende functies
Loopbaan van Marie-Paul Lachaud
Eerdere bekende functies van Marie-Paul Lachaud
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ARATANA THERAPEUTICS INC | Corporate Officer/Principal | 26-03-2013 | - |
Opleiding van Marie-Paul Lachaud
École Nationale Vétérinaire d'Alfort | Undergraduate Degree |
Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Statistieken
Internationaal
Frankrijk | 3 |
Verenigde Staten | 2 |
Operationeel
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Aratana Therapeutics, Inc.
![]() Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
- Beurs
- Insiders
- Marie-Paul Lachaud
- Ervaring